(Q35808435)

10 August 2017

1 reference

title

ABCs of radioisotopes used for radioimmunotherapy: alpha- and beta-emitters (English)

1 reference

10 August 2017

Thomas Waldmann

1

1 reference

10 August 2017

publication date

1 January 2003

1 reference

10 August 2017

1 reference

10 August 2017

volume

44 Suppl 3

1 reference

10 August 2017

page(s)

S107-13

1 reference

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Hematologic malignancies: new developments and future treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623685

10.1080/10428190310001623685

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference